Sumitomo Dainippon Pharma Co's total assets for Q4 2024 were ¥742.60B, a decrease of -12.85% from the previous quarter. JP:4506 total liabilities were ¥573.13B for the fiscal quarter, a -16.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.